Additional file 1 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis

Autor: Zhong, Ran, Gao, Rui, Fu, Wenhai, Li, Caichen, Huo, Zhenyu, Gao, Yuewen, Lu, Yi, Li, Feng, Ge, Fan, Tu, Hengjia, You, Zhixuan, He, Jianxing, Liang, Wenhua
Rok vydání: 2023
DOI: 10.6084/m9.figshare.22815141
Popis: Additional file 1: Figure S1. ctDNA MRD detection time points of each included study. Landmark ctDNA MRD is collected at a single, pre-specified timepoint, typically shortly after definitive therapy. Surveillance analysis evaluates longitudinal blood draws at multiple time points after definitive therapy during follow-up (at least one blood draw beyond 1 month after definitive therapy).
Databáze: OpenAIRE